Diabetes Drug Acarbose May Calm Severe Allergies By Reshaping Gut Bacteria
Graded Preliminary — mouse and cell work with a supporting human cohort analysis of unreported size, yet the mechanism has not been tested in people and the human link is observational only.
This study hints that gut bacteria metabolites like succinate may shape allergic responses.
In mice, the diabetes drug acarbose changed how gut bacteria use carbs, boosting a microbe that produces succinate. That succinate then blocked the mast cell reactions behind severe allergic shock. A look at human records found people taking similar drugs had fewer anaphylaxis cases.
Disclaimer: Research summaries are provided for informational purposes only and do not constitute medical advice. Always consult a qualified healthcare professional before making changes to your health routine.
Related Studies
All researchA Probiotic Fixed Blood Sugar in Old Male Mice, But Did Nothing for Females
Older male mice had much worse blood sugar control than females, and they were also low on citrulline (an amino acid made partly by gut…
The Gut-Brain-Skin Link: Why Omega-3s and Probiotics Keep Showing Up in Skin Studies
Your gut, brain, and skin appear to talk to each other through immune signals, hormones, and bacteria-made molecules.
A Probiotic in Fermented Milk Protected Muscle in Mice by Reshaping Bile Acids
Certain probiotic strains changed the mix of bile acids in the gut, which flipped a signal that told muscle to stop breaking down protein.